Introduction of other antineoplastic into nose, percutaneous approach

85812101 Introduction of destructive agent into eye, percutaneous approach Commodity 85812102 Introduction of other gas into eye, percutaneous approach Commodity 85812103 Introduction of analgesics, hypnotics, sedatives into eye, percutaneous approach Commodity 85812104 Introduction of pigment into eye, percutaneous approach Commodity 85812105 Introduction of other diagnostic substance into eye, percutaneous approach Commodity 85812106 Introduction of radioactive substance into eye, percutaneous approach Commodity 85812107 Introduction of other therapeutic substance into eye, percutaneous approach Commodity 85812108 Introduction of local anesthetic into eye, percutaneous approach Commodity 85812109 Introduction of anti-inflammatory into eye, percutaneous approach Commodity 85812110 Introduction of other anti-infective into eye, percutaneous approach Commodity 85812111 Introduction of oxazolidinones into eye, percutaneous approach Commodity 85812112 Introduction of monoclonal antibody into eye, percutaneous approach Commodity 85812113 Introduction of other antineoplastic into eye, percutaneous approach Commodity 85812114 Introduction of liquid brachytherapy radioisotope into eye, percutaneous approach Commodity 85812115 Introduction of destructive agent into ear, percutaneous approach Commodity 85812116 Introduction of analgesics, hypnotics, sedatives into ear, percutaneous approach Commodity 85812117 Introduction of other diagnostic substance into ear, percutaneous approach Commodity 85812118 Introduction of radioactive substance into ear, percutaneous approach Commodity 85812119 Introduction of other therapeutic substance into ear, percutaneous approach Commodity 85812120 Introduction of local anesthetic into ear, percutaneous approach Commodity 85812121 Introduction of anti-inflammatory into ear, percutaneous approach Commodity 85812122 Introduction of other anti-infective into ear, percutaneous approach Commodity 85812123 Introduction of oxazolidinones into ear, percutaneous approach Commodity 85812124 Introduction of monoclonal antibody into ear, percutaneous approach Commodity 85812125 Introduction of other antineoplastic into ear, percutaneous approach Commodity 85812126 Introduction of liquid brachytherapy radioisotope into ear, percutaneous approach Commodity 85812127 Introduction of destructive agent into nose, percutaneous approach Commodity 85812128 Introduction of analgesics, hypnotics, sedatives into nose, percutaneous approach Commodity 85812129 Introduction of other diagnostic substance into nose, percutaneous approach Commodity 85812130 Introduction of radioactive substance into nose, percutaneous approach Commodity 85812131 Introduction of other therapeutic substance into nose, percutaneous approach Commodity 85812132 Introduction of local anesthetic into nose, percutaneous approach Commodity 85812133 Introduction of serum, toxoid and vaccine into nose, percutaneous approach Commodity 85812134 Introduction of anti-inflammatory into nose, percutaneous approach Commodity 85812135 Introduction of other anti-infective into nose, percutaneous approach Commodity 85812136 Introduction of oxazolidinones into nose, percutaneous approach Commodity 85812137 Introduction of monoclonal antibody into nose, percutaneous approach Commodity 85812138 Introduction of other antineoplastic into nose, percutaneous approach You are here